Skip to main content
. 2018 Oct 3;38(40):8707–8722. doi: 10.1523/JNEUROSCI.0734-18.2018

Table 3.

Analysis of microglial process accumulation based on repeated-measures ANOVAs conducted at each distance from the CMB with condition (nondiabetic and diabetic + insulin) as a factor over time (0–60 min)

Distance Condition Time Interaction
5–10 μm F(1,28) = 0.21, p = 0.65 F(15,392) = 118.31, p < 0.001* F(15,392) = 0.63, p = 0.84
10–15 μm F(1,28) = 0.13, p = 0.71 F(15,392) = 78.10, p < 0.001* F(15,392) = 0.58, p = 0.88
15–20 μm F(1,28) = 1.56, p = 0.22 F(15,392) = 42.92, p < 0.001* F(15,392) = 1.34, p = 0.18
20–25 μm F(1,28) = 6.08, p < 0.05* F(15,392) = 13.28, p < 0.001* F(15,392) = 1.43, p = 0.14
25–30 μm F(1,28) = 1.12, p = 0.30 F(15,392) = 9.51, p < 0.001* F(15,392) = 0.56, p = 0.90
30–35 μm F(1,28) = 0.21, p = 0.64 F(15,392) = 3.51, p < 0.001* F(15,392) = 0.19, p = 0.99

*Significant main effects.